Associate ProfessorJenna Ziebell

Associate Professor

Wicking Dementia Research Education Centre

  • Associate Professor
    Wicking Dementia Research Education Centre
  • +61 3 6226 4705 (Work)
  • Wicking Dementia Research Education Centre, Wicking Dementia Research and Education Centre, 417-25 (Level 4) Medical Science 1, Hobart CBD Campuses, TAS

RESEARCH SUMMARy

Research Themes

Dr Ziebell’s research aligns to the University’s Brain Science, Behaviour and Neurological Diseases research theme. Her research interests include experimental models of neurological disease including traumatic brain injury and dementia. Dr Ziebell’s research primarily focuses on the inflammatory cascades initiated in these diseases and how this influences disease progression, neuronal circuits, as well as cognition and motor function.
Current projects

Current projects include:
1. Microglia: does their role in synaptic remodelling change with age?
2. How do microglia:synapse dynamics change with Alzheimer’s disease?
3. Are microglia drivers of Alzheimer's disease?
4. How do microglia contribute to obesity, insulin resistance and type 2 diabetes?

FUNDED PROJECTS

  • GRANT
    Acquisition of a high-frequency ultrasound platform to supercharge discovery research in Tasmania
    1 Jan 2027 - 31 Dec 2029
    People funded by this grant:
    • Premilovac D,
    • Sutherland B,
    • Young K,
    • Flies A,
    • Guven N
    Project Total: $141,000; This equipment grant application to the Ian Potter Foundation will lead to acquisition of a new, purpose built and state of the art ultrasound machine for preclinical work. Currently available machines at UTAS are clinical machines and are not able to adequately support preclinical imaging due to temporal and spatial resolution limits. This new machine will enable live in vivo imaging of any organ in the rat/mouse/zebra fish, measurement of cardiovascular function, targeted drug delivery using microbubbles (contrast agents) and an ultrasound guided micro-injection platform for delivery of compounds or genetic material without off target effects. Funded by: Ian Potter Foundation - Grant - Medical Research ($141,000); University of Tasmania ($141,000).
  • GRANT
    From mood to memory: how antidepressants impact on Alzheimers disease progression.
    1 Mar 2026 - 1 Mar 2028
    People funded by this grant:
    • Doust Y,
    • Ziebell J,
    • Salahudeen M
    Project Total: $85,000; Depression is a common neuropsychiatric symptom in individuals with Alzheimers disease (AD), often emerging in the early to middle stages of the condition. Selective Serotonin Reuptake Inhibitors (SSRIs) are frequently prescribed to manage depressive symptoms due to their favourable safety profile and tolerability in older adults. Emerging evidence suggests that SSRIs may influence AD pathology and progression, yet their precise role remains unclear. This study aims to investigate the effects of SSRIs on pathological and functional outcomes in AD, integrating clinical and preclinical approaches to enhance translational relevance. We will analyse large-scale clinical databases containing information on SSRI use, cognitive performance, neuroimaging, and serum biomarkers to identify which SSRIs are associated with reduced disease burden in Australians living with AD. These findings will inform the design of mechanistic studies using male and female 3xTg AD mice, a well-characterised model of AD. Mice will receive either acute or chronic SSRI treatment, with comparisons made to untreated controls. Monthly assessments of cognitive and motor function will be conducted, alongside serial blood sampling for biomarker analysis. Following 8 weeks of SSRI exposure, brain tissue will be collected to evaluate amyloid and tau pathology, blood-brain barrier integrity, and glial reactivity. This approach will allow us to determine whether SSRI exposure alters key pathological features of AD and identify potential mechanisms underlying these effects. By directly linking clinical observations with mechanistic outcomes, this research will clarify the role of SSRIs in AD progression and support the development of evidence-based strategies for managing depression in dementia. Funded by: Dementia Australia Research Foundation Ltd - Project Grant ($84,981); University of Tasmania ($231,125).
  • GRANT
    Mind the Gap: Partnering with consumers to implement person centred concussion management
    1 Jun 2025 - 31 May 2027
    People funded by this grant:
    • Barlow K,
    • Ponsford J,
    • Cudmore T,
    • Tavender E,
    • Anderson V
    Project Total: $721,092; There is a considerable gap in the care of people with concussion where 30% of people can have long-lasting symptoms profoundly impacting their function and ability to go to work or school. Indeed, over two thirds of people with persisting post-concussion symptoms (PPCS) fail to get the timely care they need. Clinician confidence in providing care in this complex condition is low, and navigating the health care system is difficult due the lack of clear pathways to access care and limited publicly funded specialized concussion services, especially in rural and regional Australia. The investigators have completed the first Australian Clinical Practice Guidelines for the Management of Concussion and Post-Concussion Symptoms (ANZ CPG) to help clinicians deliver best-practice care. To be effective, guidelines need strategic implementation using strategies tailored to the population. This research aims to bridge this gap in care by codesigning and piloting a new patient-driven model of care that powered by a new Concussion Conversation Tool (CCT) and integrated with specialized services. We will do this using a Human Centred Design framework where patients and community clinicians play a pivotal role. We will build on our previous work and an existing concussion health pathway prototype. After in-depth mapping of the patient journey and services in QLD and VIC, we will create i) a novel tool, the CCT to increase knowledge, greater adherence to the ANZ CPG, and improve shared decision-making. We will then ii) integrate this into an enhanced Concussion Health Pathway (CHP) with navigation features to access care and linkages with educational resources (developed as part of the TBI Mission) and specialized services. Finally, we will pilot the new model of care using a quasi-experimental design across four sites representing both urban and rural communities to access its feasibility and acceptability for a later hybrid effectiveness implementation trial. Funded by: Medical Research Future Fund - Grant - Traumatic Brain Injury Mission; University of Queensland; University of Tasmania.
  • GRANT
    Checking the pulse of pericytes: Do microglia cause a breakdown of brain blood vessels in Alzheimer's disease?
    1 Jul 2024 - 30 Jun 2028
    People funded by this grant:
    • Sutherland B,
    • Morris G,
    • De Luca G,
    • Ziebell J
    Project Total: $1,278,438; Pericytes are cells that control blood flow through capillaries. Microglia in the brain respond to inflammation. Some microglia interact with pericytes which may control blood flow and brain function. In Alzheimers disease (AD), this interaction is disrupted. This proposal will use innovative techniques to understand how pericytes and microglia interact and how this goes wrong in AD. This opens up new potential treatment options for AD. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Ideas ($2,556,876); University of Tasmania ($116,214).
  • GRANT
    CLN3 disease: are microglia the problem?
    8 Mar 2024 - 9 Feb 2025
    People funded by this grant:
    • Ziebell J,
    • Cook T,
    • Doust Y,
    • Perry S,
    • Thorne B
    Project Total: $25,718; This original and novel research paradigm investigates innovative concepts and pathways to further our understanding of CLN3 pathogenesis and will likely highlight new approaches for therapeutic intervention by understanding if microglia are driving disease progression. Funded by: Batten Disease Support and Research Association Australia - Grant ($25,718); University of Tasmania.
  • GRANT
    Alternate drivers of Alzheimer's disease: Are microglia the problem?
    1 Jul 2023 - 30 Jun 2026
    People funded by this grant:
    • Ziebell J,
    • King A,
    • Doust Y
    Project Total: $326,358; This research aims to understand if microglia are genetically programmed to drive Alzheimers disease progression. Recent studies suggest microglia are highly associated with Alzheimers disease and could potentially be the initiators of disease. We know microglial functional capacity changes with increasing plaque burden (hallmark of AD). Additional evidence demonstrates microglia have innate differences dependent on biological sex. These innate differences in microglia could partially explain why females are twice as likely than males to develop Alzheimers disease. Our innovative research plan combines these past findings to investigate whether transplanting microglia from healthy? mice diminishes disease burden. Further, we will examine whether transplanting microglia from Alzheimers disease? mice changes neuropathology with ageing. Our study design will investigate these factors in both biological sexes. Funded by: National Foundation for Medical Research and Innovation - Grant-Expression of Interest ($326,358); University of Tasmania.
  • GRANT
    Translating Awareness, Literacy, and Knowledge of Traumatic Brain Injury (TALK-TBI)
    1 Jun 2021 - 31 May 2027
    People funded by this grant:
    • Ziebell J,
    • Cook P,
    • Doherty K,
    • Eccleston C,
    • Schramm T
    Project Total: $999,998; The proposal has outstanding levels of community engagement. The team has allocated time (milestone indicators) and resources (budget) for extended community engagement at all stages of the project making the proposal highly feasible. Additionally, we have already established relationships with Aboriginal and Torres Strait Islander communities. Tasmanian Aboriginal Centre (TAC) and CI Schramm have assisted with the design of the project and TAC have agreed to host at least one Aboriginal health worker for the duration of this project. In addition, TAC has confirmed the transferability of the skills (e.g. communication, analysis, education design) gained from working on this project are highly desirable for future research and education programs. The incidence of TBI in the Aboriginal and Torres Strait Islander communities is almost twice the national average this means urgent attention is needed to increase awareness and educate. Tasmanian Aboriginal Centre (TAC) has indicated to the research team that brain injury awareness and education are a priority for their communities. Our research proposal aims to not only establish awareness of TBI but also the lived experience of those who have sustained a TBI. Accounts can be captured in their language making the applicability to others in the community stronger. These personal accounts may also identify areas of need for specific educational programs, which are culturally appropriate and can be developed in consultation with the local communities. Funded by: Medical Research Future Fund - Grant - Traumatic Brain Injury Mission ($999,998); University of Tasmania.
  • GRANT
    Why do we have SARM 1 protein if knocking it out prevents axons degenerating?
    1 Jan 2020 - 30 Jun 2024
    People funded by this grant:
    • King A,
    • Canty A,
    • Cook T,
    • Perry S
    Project Total: $597,651; Loss of axonal connections between nerve cells results in reduced cognitive function and memory loss. Axons, like cells, can orchestrate their own death mechanisms and the SARM1 protein mediates Wallerian degeneration the best known axon death pathway. It is not yet understood, why neurons have evolved to have this axon degeneration pathway; whether it is aberrantly activate in neurodegenerative disease or whether it protects the nervous system from adverse nerve cell connections. By using a combination of methods, including axon injury and neurodegeneration mouse models, and human stem cell research, we will identify the exact role of SARM1 in the response to injury and neurodegeneration and determine whether blocking axons from this protein is beneficial or harmful. Our team is comprised of world leaders in investigating axon pathology, degeneration and regeneration in neurodegenerative disease and injury, and outcomes of this research will advance treatment of diseases such as dementia and motor-neuron disease. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Ideas ($1,195,302); University of Tasmania.
  • GRANT
    Could gut microbiota influence cognitive decline and Alzheimer's disease?
    16 May 2018 - 16 May 2020
    People funded by this grant:
    • Ziebell J,
    • King A,
    • Lea E
    Project Total: $66,115; This pilot grant will map gut microbiota in three populations: A) Individuals with a clinical diagnosis of dementia: Individuals identified by a clinician as living with dementia will be recruited (n=20). These individuals must be residing in the community as gut microbiota alterations are known to be dependent on the environment (13). B) Spousal caregivers for those living with dementia: Carers of individuals living with dementia are six times more likely to develop dementia (14). Stress is a leading theory for this occurrence, however shared gut microbiota is a potential unexplored link. This group potentially represents the pre-clinical population where alterations to gut microbiota are occurring before symptoms are established (n=20). C) Spousal caregivers providing informal care to someone who does not have dementia: A cohort of individuals providing care to a spouse living with a chronic illness will be recruited (n=20). This group will provide evidence as to whether the disease and/or gut microbiota influence AD development. By determining the gut microbiota diversity in these populations, we will begin to understand whether gut microbiota influences cognitive decline and dementia. Initially this will be a cross-sectional study but if data are promising then it will lead to a longitudinal study. Funded by: uBiome, Inc. - Grant; University of Tasmania.
  • GRANT
    Can microglia priming influence neurodegeneration?
    1 Jan 2018 - 31 Dec 2018
    People funded by this grant:
    • Ziebell J,
    • King A,
    • Lea E
    Project Total: $10,000; Inflammation has been implicated in premature ageing of the brain and the development of neurological disease (1). Microglia are the inflammatory cells of the brain, and currently it is unclear whether they are active (driving pathology) or passive (a bystander) in the ageing and neurodegenerative processes. In response to disturbances in the microenvironment microglia are capable of secreting both pro- and anti-inflammatory cytokines to restore homeostasis. With subsequent disturbances, microglia mount an exaggerated response, due to priming. Increasing age impedes microglia's ability to perform the most essential of homeostatic functions. At this time microglia are known as dystrophic; stuck in a pro-inflammatory phenotype. Understanding this switch? to a pro-inflammatory state may aid in preventing the effects of ageing through modulation of microglial activity and offers a novel target for therapy to slow the progression of neurological disease. For this to be effective, we must first define the precise roles of microglia in ageing and neurodegeneration. By determining microglial phenotype throughout disease progression we can gain insight into their role in disease pathology. Funded by: University of Tasmania - Grant-Strategic Research; University of Tasmania ($10,000).
  • GRANT
    How do microglia-synapse dynamics change with Alzheimer's disease?
    1 Jan 2017 - 1 Mar 2019
    People funded by this grant:
    • Ziebell J,
    • Canty A,
    • King A
    Project Total: $50,000; This project explores the emerging role of microglia in facilitating changes to neuronal connections, synaptic plasticity or the ability of the brain to remodel throughout the lifespan in response to a changing environment. Using state of the art imaging techniques, this project will explore microglia-synapse interactions in real time, to elucidate the role microglia play in synaptic plasticty in Alzheimer's disease and throughout ageing. Funded by: Dementia Australia Research Foundation Ltd - Grant-Dementia Grants Program ($50,000); University of Tasmania.
  • GRANT
    Microglia: Does their role in synaptic remodelling change with age?
    1 Jan 2016 - 31 Dec 2016
    People funded by this grant:
    • Ziebell J
    Project Total: $15,000; Funded by: University of Tasmania - Grant-Research Enhancement (REGS); University of Tasmania ($15,000).